The global biodegradable stents market is entering a new phase of innovation and commercial expansion as healthcare systems, clinicians, and patients increasingly turn toward technologies that offer temporary vascular support without the long-term complications associated with permanent implants. With the market valued at US$ 351.6 million in 2023, this sector is expected to undergo a significant transformation over the coming decade, ultimately reaching US$ 809.2 million by 2034. This trajectory reflects a growing confidence in bioresorbable materials, advancements in device engineering, and a heightened clinical emphasis on minimally invasive procedures that improve patient outcomes.

Request a sample report copy

Market Overview

Biodegradable stents are designed to address some of the key limitations of traditional metal stents, which remain indefinitely in the body and may cause chronic inflammation, hinder future interventions, or trigger late-stage thrombosis. By contrast, biodegradable stents provide necessary structural support to the vessel during healing and gradually dissolve afterward, leaving the artery free of foreign materials. This concept is reshaping therapeutic approaches in interventional cardiology, gastroenterology, and peripheral vascular medicine, where the demand for advanced, patient-friendly solutions continues to rise. With improvements in manufacturing technologies, drug-elution capabilities, and bioresorbable material science, these devices are capturing increasing market attention and investment.

Market Size and Growth

The market’s growth prospects are underpinned by robust clinical demand and steady technological progress. With a baseline valuation of US$ 351.6 Mn in 2023, the biodegradable stents industry is projected to expand at a CAGR of 7.8% from 2024 to 2034, nearly doubling its size within the forecast period. This expansion is largely attributable to the rising incidence of cardiovascular disease worldwide, particularly in countries experiencing demographic aging and lifestyle-related health challenges. Furthermore, next-generation bioresorbable stents are showing improvements in radial strength, scaffold stability, and controlled degradation—features that enhance their clinical utility and help build physician confidence.

Market Segmentation

The biodegradable stents market can be examined through multiple segmentation lenses, with each segment offering important insights into technological evolution and clinical adoption. By material type, polymer-based stents hold the dominant share due to their extensive clinical history and ability to deliver anti-proliferative drugs via drug-eluting systems. However, emerging interest in magnesium- and zinc-based alloys signals a shift toward bioresorbable metals that potentially offer superior mechanical performance. By application, coronary artery disease remains the primary driver of demand, but non-vascular applications such as biliary and esophageal stenting are gaining traction as clinical evidence mounts. By end-use, hospitals and specialized cardiac centers continue to lead adoption, thanks to their advanced interventional capabilities and access to experienced physicians.

Regional Analysis

Market performance varies widely by region, influenced by healthcare infrastructure, regulatory landscapes, and procedural volumes. North America and Europe currently command the largest revenue shares, supported by strong clinical research ecosystems, widespread adoption of cutting-edge cardiovascular technologies, and favorable reimbursement systems. These regions are also home to many leading device manufacturers and clinical trial centers. Asia Pacific, however, is forecast to exhibit the most rapid growth, driven by rising healthcare expenditures, expanding access to interventional cardiology services, and a large patient population with unmet cardiovascular care needs. Countries such as China, India, and Japan are emerging as key markets, both for clinical use and manufacturing partnerships. Meanwhile, Latin America and the Middle East are expected to contribute gradually to the global market as investments in healthcare modernization accelerate.

Market Drivers and Challenges

Several powerful drivers are shaping the future of the biodegradable stents market. The global burden of cardiovascular disease remains high, generating sustained demand for safer, more effective interventional tools. Minimally invasive procedures continue to replace traditional surgical approaches, and biodegradable devices align well with this shift by reducing long-term foreign body complications. Ongoing improvements in stent materials, coating technologies, and degradation processes are further strengthening market performance. Despite these positive drivers, the industry faces challenges. High product costs remain a meaningful barrier in price-sensitive markets. Regulatory pathways for biodegradable materials are complex, resulting in lengthy approval timelines. Furthermore, concerns stemming from early-generation devices have required extensive clinical validation to reassure physicians and patients. The need for long-term outcome data remains a constraint but is gradually being addressed by new studies.

Market Trends

The biodegradable stents market is undergoing a period of dynamic change, characterized by trends that reflect a growing maturity of the technology. One of the most significant trends is the shift toward fully bioresorbable drug-eluting stents, which combine structural support with targeted therapeutic delivery to prevent restenosis. Another major trend is the growing use of bioresorbable metallic alloys, particularly magnesium-based scaffolds, which offer improved mechanical strength and controlled degradation compared to polymer-only systems. Additionally, the integration of imaging-guided deployment techniques—such as OCT and IVUS—is helping clinicians place stents with greater precision, improving patient outcomes and supporting broader adoption. As more data becomes available from long-term clinical trials, the perception of biodegradable stents is shifting from experimental to mainstream.

Competitive Landscape

Competition within the biodegradable stents industry is intensifying as global players expand their portfolios and invest heavily in research and development. Major companies—including Boston Scientific, Abbott, Elixir Medical Corporation, KYOTO MEDICAL PLANNING Co., Ltd., Biotronik, Terumo Corporation, Biosensors International Group, ELLA-CS, s.r.o., and SMT—are driving innovation through next-generation designs, clinical trials, and strategic collaborations. Abbott has been one of the pioneers in bioresorbable scaffold technologies, while Boston Scientific continues to advance polymer stent innovation. Meanwhile, emerging companies and regional manufacturers are entering the field with novel biomaterials and competitive pricing strategies, further enhancing market dynamism and accelerating global adoption.

About Transparency Market Research

Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyses information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact:

Transparency Market Research Inc.

CORPORATE HEADQUARTER DOWNTOWN,

1000 N. West Street,

Suite 1200, Wilmington, Delaware 19801 USA

Tel: +1-518-618-1030

USA – Canada Toll Free: 866-552-3453